Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement

J. Wesson Ashford, Frederick A. Schmitt, Michael F. Bergeron, Peter J. Bayley, James O. Clifford, Qun Xu, Xiaolei Liu, Xianbo Zhou, Vinod Kumar, Herman Buschke, Margaret Dean, Sanford I. Finkel, Lee Hyer, George Perry

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Wang et al. analyze Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment accuracy as screening tests for detecting dementia associated with Alzheimer's disease (AD). Such tests are at the center of controversy regarding recognition and treatment of AD. The continued widespread use of tools such as MMSE (1975) underscores the failure of advancing cognitive screening and assessment, which has hampered the development and evaluation of AD treatments. It is time to employ readily available, efficient computerized measures for population/mass screening, clinical assessment of dementia progression, and accurate determination of approaches for prevention and treatment of AD and related conditions.

Original languageEnglish
Pages (from-to)305-315
Number of pages11
JournalJournal of Alzheimer's Disease
Issue number1
StatePublished - 2022

Bibliographical note

Publisher Copyright:
© 2022-IOS Press. All rights reserved.


  • Alzheimer's disease
  • MemTrax
  • Mini-Mental State Examination
  • Montreal Cognitive Assessment
  • cognition assessment
  • computerized testing
  • neuroplasticity

ASJC Scopus subject areas

  • Neuroscience (all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health


Dive into the research topics of 'Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement'. Together they form a unique fingerprint.

Cite this